Total New Medical Entities by Pharma Company 1999-2018. Modified from "R&D efficiency of leading pharmaceutical companies – A 20-year analysis" Last week I published an article on the three academic ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

A conversation with Upperton’s Director of Pharmaceutical Sciences, Laura Mason about the upcoming trends she sees emerging ...

Artios Pharma collected $115 million from an oversubscribed series D that will support its growing ambitions for its pipeline ...

Traws Pharma published promising data on rigosertib for treating RDEB-associated SCC, showing an 80% response rate in clinical trials. The company is actively seeking development and commercialization ...

Pharma’s return on investment (ROI) for research and development (R&D) is seeing a comeback after a record low in 2022, according to a recent report out of Deloitte. ROI on pharma R&D jumped to 4.1% ...

SALZBURG, Austria--(BUSINESS WIRE)--After successfully launching the D-mine ® Pump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson´s patients, EVER ...

Modern medicine as we know it wasn’t shaped by doctors alone—it was engineered by John D. Rockefeller. In the early 20th century, Rockefeller and his oil empire helped transform medicine into a ...